Wolverine Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Hold |
0
| – | – | – | 1392 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 1390 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 1310 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 1153 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 1192 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1167 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1140 |
|
|
2016
Q3 | – | Sell |
-285
| Closed | -$21K | – | 796 |
|
|
2016
Q2 | $21K | Buy |
+285
| New | +$21K | ﹤0.01% | 587 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 1126 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 1155 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 1162 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 1199 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 1284 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 1316 |
|